International Symposium on Malignant Pleural Mesothelioma Conference
Posted on Wednesday, January 18th, 2017 at 7:21 am
International Symposium on Malignant Pleural Mesothelioma Conference September 2016
Dr. Robert Cameron, a thoracic surgeon and renowned mesothelioma specialist hosted the 6th International Symposium on Malignant Pleural Mesothelioma. The International Symposium on Malignant Pleural Mesothelioma was set for the 26th September 2016 at the UCLA School of Medicine. Dr. Cameron is director of the UCLA Comprehensive Mesothelioma Program. He is also a global leader in the development of the lung-sparing pleurectomy and a vocal advocate for military veterans who develop the asbestos related disease – mesothelioma.
The conference was said to cover the newest in mesothelioma therapies including:
Pleural Mesothelioma
- Immunotherapies
- Gene therapies
- Upcoming clinical trials and
- Advances in surgery
The reason for such discussions was said to be to have a better understanding of many different treatments, create awareness of the many types of immunological therapies and stress the need to treat mesothelioma as a serious chronic disease.
International Symposium on Malignant Pleural Mesothelioma Attendees
Most noteworthy is the many medical professionals were said to be attending the International Symposium on Malignant Pleural Mesothelioma such as surgeons, nurses, medical students, oncologist, pulmonologists as well as mesothelioma advocates, patients and families. Furthermore, all these would be from across the nation and they would meet to discuss and exchange ideas and thoughts. The symposium also stands to benefit those in attendance as they learn of new developments on treating patients. The symposium will also allow for interaction of both patients and medical professionals.
Mesothelioma is a rare and aggressive cancer that is caused by exposure to asbestos fibers over a period of time. It is diagnosed in some three thousand people each year in the U. S. There is no known cure for mesothelioma. As a result most available treatment focuses on the prolonging of life of patients and not on the curing of the disease.
In conclusion, the symposium allows all in attendance a learning experience about the disease.